project id: TCGA-PAAD; case submitter id: TCGA-XD-AAUG; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.97; rna integrity number: 7.5; age at index: 66; days to birth: -24291; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1947; age at diagnosis: 24291; ajcc pathologic m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 420.0; icd 10 code: C25.1; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of pancreas; synchronous malignancy: No; tissue or organ of origin: Body of pancreas; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 67; days to sample procurement: 0; initial weight: 1140.0; portion submitter id: TCGA-XD-AAUG-01A-61; percent lymphocyte infiltration: 70.0; percent monocyte infiltration: 10.0; percent necrosis: 0.0; percent neutrophil infiltration: 10.0; percent normal cells: 20.0; percent stromal cells: 30.0; percent tumor cells: 50.0; percent tumor nuclei: 50.0;